14 insiders reported 113 Form 4 transactions for Crinetics Pharmaceuticals, Inc. (CRNX) over the past 18 months (most recent 2026-09-01). Recent activity: Betz Stephen F. (Chief Scientific Officer) Sell 58,286 shares, Deardorf Caren (Director) Sell 5,925 shares, Fust Matthew K (Director) Sell 22,836 shares, Vivaldi Coelho Rogerio (Director) Sell 13,300 shares, Schilke Tobin (Chief Financial & Infra. Ofcr.) Sell 7,956 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Betz Stephen F. | Chief Scientific Officer | Sell | 58,286 | $5.0M |
| 2026-09-01 | Deardorf Caren | Director | Sell | 5,925 | $503,625 |
| 2026-09-01 | Fust Matthew K | Director | Sell | 22,836 | $1.9M |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Sell | 13,300 | $1.1M |
| 2026-09-01 | Schilke Tobin | Chief Financial & Infra. Ofcr. | Sell | 7,956 | $676,260 |
| 2026-09-01 | Okey Stephanie | Director | Sell | 6,400 | $544,000 |
| 2026-09-01 | Struthers Richard Scott | President & CEO | Sell | 248,043 | $21.1M |
| 2026-09-01 | Struthers Richard Scott | President & CEO | Sell | 110,000 | $9.3M |
| 2026-09-01 | Deardorf Caren | Director | Sell | 16,300 | $1.4M |
| 2026-09-01 | WIERENGA WENDELL | Director | Sell | 116,146 | $9.9M |
| 2026-09-01 | Kalofonos Isabel | Chief Commercial Officer | Sell | 1,669 | $141,865 |
| 2026-09-01 | WIERENGA WENDELL | Director | Sell | 5,925 | $503,625 |
| 2026-09-01 | Bedrosian Camille L | Director | Sell | 5,925 | $503,625 |
| 2026-09-01 | Fust Matthew K | Director | Sell | 5,925 | $503,625 |
| 2026-09-01 | Vivaldi Coelho Rogerio | Director | Sell | 5,925 | $503,625 |
| 2026-09-01 | Schilke Tobin | Chief Financial & Infra. Ofcr. | Sell | 71,471 | $6.1M |
| 2026-09-01 | Okey Stephanie | Director | Sell | 5,925 | $503,625 |
| 2026-09-01 | Struthers Richard Scott | President & CEO | Sell | 1,000 | $85,000 |
| 2026-09-01 | Nichols Weston | Director | Sell | 5,925 | $503,625 |
| 2026-09-01 | Bedrosian Camille L | Director | Sell | 16,300 | $1.4M |
| 2026-09-01 | Betz Stephen F. | Chief Scientific Officer | Sell | 79,650 | $6.8M |
| 2026-09-01 | Kalofonos Isabel | Chief Commercial Officer | Sell | 34,000 | $2.9M |
| 2026-09-01 | Struthers Richard Scott | President & CEO | Sell | 136,805 | $11.6M |
| 2026-09-01 | Struthers Richard Scott | President & CEO | Sell | 106,000 | $9.0M |
| 2026-09-01 | Nichols Weston | Director | Sell | 16,300 | $1.4M |
Source: SEC Form 4 filings · as of 2026-09-01